Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2024.Oct.07

Announcement of issue price and banks designated to collect and deposit the proceeds for 2024 cash capital increase

2024.Sep.25

Announcement on behalf of OBIGEN of the Board’s resolution to lift the non-competition restrictions for CEO

2024.Sep.24

Announcement of reference date of cash capital increase and share subscription

2024.Aug.07

OBI receives US FDA Orphan Drug Designation for OBI-992 TROP2 ADC for the treatment of gastric cancer

2024.Aug.02

Announcement of change of accounting officer

2024.Aug.02

Announcement of change of acting spokesperson

2024.Aug.02

Announcement of new appointment of Chief Operating Officer

2024.Aug.02

Announcement of adjustment of an item in the plan of 2018 cash capital increase

2024.Aug.02

Announcement of BOD’s resolution to issue common shares through cash capital increase in 2024

2024.Aug.02

Announcement of the Consolidated Financial Statements for the second quarter of 2024 were approved by the Board of Directors.

News

Latest News

Events

Latest events